Obesity
Showing NaN - NaN of 53
Obesity Trial in United States (S-2367 (velneperit))
Completed
- Obesity
- S-2367 (velneperit)
-
Birmingham, Alabama
- +72 more
Apr 26, 2018
Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- liraglutide
- placebo
-
Birmingham, Alabama
- +225 more
Dec 20, 2017
Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- liraglutide
- placebo
-
Vestavia Hills, Alabama
- +160 more
Dec 6, 2017
Metabolism and Nutrition Disorder, Obesity Trial in Canada, United States (liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- liraglutide
- placebo
-
Goodyear, Arizona
- +36 more
Sep 29, 2017
Obesity, Cardiovascular Diseases Trial in United States (Naltrexone HCl/Bupropion HCl ER, Placebo)
Terminated
- Obesity
- Cardiovascular Diseases
- Naltrexone HCl/Bupropion HCl ER
- Placebo
-
Alexander City, Alabama
- +138 more
Feb 21, 2017
Obesity Trial in Cincinnati (Behavioral Family Intervention, Motivational Interviewing)
Completed
- Obesity
- Behavioral Family Intervention
- Motivational Interviewing
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Dec 27, 2016
Obesity Trial in Cincinnati (Cooking)
Completed
- Obesity
- Cooking
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jul 13, 2015
Obesity Trial in United States (pramlintide acetate, )
Completed
- Obesity
- pramlintide acetate
- placebo
-
Chula Vista, California
- +20 more
Jun 10, 2015
Obesity Trial in United States (Placebo, Pramlintide and Metreleptin)
Completed
- Obesity
- Placebo
- Pramlintide and Metreleptin
-
Birmingham, Alabama
- +32 more
Mar 26, 2015
Overweight, Obesity Trial in United States (pramlintide acetate, metreleptin, -P)
Completed
- Overweight
- Obesity
- pramlintide acetate
- +3 more
-
Birmingham, Alabama
- +35 more
Mar 26, 2015
Overweight, Obesity Trial in United States (pramlintide acetate 360 mcg, metreleptin, -pramlintide 600 uL)
Completed
- Overweight
- Obesity
- pramlintide acetate 360 mcg
- +4 more
-
Deland, Florida
- +11 more
Mar 26, 2015
Obesity Trial in United States (pramlintide acetate)
Completed
- Obesity
- pramlintide acetate
-
Chula Vista, California
- +20 more
Apr 9, 2015
Obesity Trial in Cincinnati (Blueberry Smoothie, Sham Smoothie)
Completed
- Obesity
- Blueberry Smoothie
- Sham Smoothie
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Dec 16, 2014
Obesity, Overweight Trial in United States (Naltrexone SR 32 mg/bupropion SR 360 mg/day, Placebo, Ancillary therapy)
Completed
- Obesity
- Overweight
- Naltrexone SR 32 mg/bupropion SR 360 mg/day
- +2 more
-
Phoenix, Arizona
- +35 more
Nov 18, 2014
Obesity Trial in Cincinnati (Clinic + Home Behavioral Intervention, Pediatrician Counseling, Clinic Only Behavioral
Completed
- Obesity
- Clinic + Home Behavioral Intervention
- +2 more
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Oct 20, 2014
Development of PK/PD Model for Individualized Propofol Dosing
Completed
- Obesity
- Elective Surgery
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jan 8, 2014
Obesity, Insulin Resistance Trial in Worldwide (MICARDIS® (telmisartan))
Completed
- Obesity
- Insulin Resistance
- MICARDIS® (telmisartan)
-
Los Angeles, California
- +16 more
Oct 31, 2013
CV Disease in Adolescents With Type 2 Diabetes
Completed
- Cardiovascular Diseases
- +3 more
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jul 31, 2012
Evaluation of a Weight Management Program
Completed
- Obesity
- Comprehensive weight management program
-
Fort Wayne, Indiana
- +3 more
Sep 21, 2011
Obesity, Weight Loss Trial in Canada, United States (Rimonabant (SR141716))
Completed
- Obesity
- Weight Loss
- Rimonabant (SR141716)
-
Birmingham, Alabama
- +50 more
Apr 17, 2009
Obesity, Dyslipidemia Trial in Worldwide (Rimonabant (SR141716))
Completed
- Obesity
- Dyslipidemia
- Rimonabant (SR141716)
-
Mesa, Arizona
- +34 more
Apr 17, 2009